Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366285231> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4366285231 abstract "Introduction: Thymol has an antiprotozoal effect. Nanoparticulate systems are useful carriers for both small and large drug molecules, which can protect them from some chemical and biological damages as well as target drug delivery to specific organs or receptors. In this work, the nano-liposomal system and solid lipid nanoparticles loaded by thymol were prepared and the effectiveness of them were evaluated on Leishmania major promastigotes.
 Methods: Several formulations of nano-liposomes and solid lipid nanoparticles were prepared, and the amount of thymol loading, in-vitro release profile, particle size, and zeta potential were evaluated. Finally, the best formulations were serially diluted and incubated for 24, 48, and 72 hours on Leishmania major promastigotes, which cultured on Novy–MacNeal–Nicolle medium, and the results were analyzed.
 Results: The highest loading of thymol in nano-liposomes (92%) was seen in the formulations made with phosphatidylcholine (Called L3), and among the solid lipid nanoparticles, the formulation prepared with glycerol monostearate (S1) had the most entrapment efficiency of thymol (87%). These formulations were selected to evaluate the release rate of thymol. The results showed that S1 has a slower release rate than L3; this may be due to the presence of Glycerol monostearate in solid lipid nanoparticles structure. The best formulations, L3 and S1, were chosen for anti-Leishmaniosis assessment; which showed that all three forms of free thymol, nanoliposomes, and solid lipid nanoparticles inhibited Leishmania major. The half maximal inhibitory concentration (IC50) of free thymol, nanoliposome, and solid lipid nanoparticles for a 24-hour incubation are 7.8, 62.5, and 125, respectively, which decrease to 7.8, 7.8, and 15.6 for 48 hours and 7.8, 0.49, and 0 for 72 hours of incubation.
 Conclusion: Thymol has a significant effect on the inhibition of Leishmania major promastigotes and usage of thymol in the form of liposomes or solid lipid nanoparticles can sustain the drug release and have a lower IC50 during the longer incubation time." @default.
- W4366285231 created "2023-04-20" @default.
- W4366285231 creator A5008552580 @default.
- W4366285231 creator A5021875895 @default.
- W4366285231 creator A5025855826 @default.
- W4366285231 creator A5038659443 @default.
- W4366285231 creator A5070066594 @default.
- W4366285231 date "2023-04-17" @default.
- W4366285231 modified "2023-10-18" @default.
- W4366285231 title "Preparation of Thymol Nanoliposome and Solid Lipid Nanoparticle and Evaluation of their Inhibitory Effects on Leishmania Major Promastigotes" @default.
- W4366285231 doi "https://doi.org/10.18502/aptj.v3i1.12501" @default.
- W4366285231 hasPublicationYear "2023" @default.
- W4366285231 type Work @default.
- W4366285231 citedByCount "0" @default.
- W4366285231 crossrefType "journal-article" @default.
- W4366285231 hasAuthorship W4366285231A5008552580 @default.
- W4366285231 hasAuthorship W4366285231A5021875895 @default.
- W4366285231 hasAuthorship W4366285231A5025855826 @default.
- W4366285231 hasAuthorship W4366285231A5038659443 @default.
- W4366285231 hasAuthorship W4366285231A5070066594 @default.
- W4366285231 hasConcept C147789679 @default.
- W4366285231 hasConcept C155672457 @default.
- W4366285231 hasConcept C171250308 @default.
- W4366285231 hasConcept C178790620 @default.
- W4366285231 hasConcept C185154212 @default.
- W4366285231 hasConcept C185592680 @default.
- W4366285231 hasConcept C187530423 @default.
- W4366285231 hasConcept C192562407 @default.
- W4366285231 hasConcept C199529486 @default.
- W4366285231 hasConcept C2776330855 @default.
- W4366285231 hasConcept C2777278459 @default.
- W4366285231 hasConcept C2778918659 @default.
- W4366285231 hasConcept C2779820397 @default.
- W4366285231 hasConcept C2780642067 @default.
- W4366285231 hasConcept C41625074 @default.
- W4366285231 hasConcept C43617362 @default.
- W4366285231 hasConcept C55493867 @default.
- W4366285231 hasConcept C86181022 @default.
- W4366285231 hasConceptScore W4366285231C147789679 @default.
- W4366285231 hasConceptScore W4366285231C155672457 @default.
- W4366285231 hasConceptScore W4366285231C171250308 @default.
- W4366285231 hasConceptScore W4366285231C178790620 @default.
- W4366285231 hasConceptScore W4366285231C185154212 @default.
- W4366285231 hasConceptScore W4366285231C185592680 @default.
- W4366285231 hasConceptScore W4366285231C187530423 @default.
- W4366285231 hasConceptScore W4366285231C192562407 @default.
- W4366285231 hasConceptScore W4366285231C199529486 @default.
- W4366285231 hasConceptScore W4366285231C2776330855 @default.
- W4366285231 hasConceptScore W4366285231C2777278459 @default.
- W4366285231 hasConceptScore W4366285231C2778918659 @default.
- W4366285231 hasConceptScore W4366285231C2779820397 @default.
- W4366285231 hasConceptScore W4366285231C2780642067 @default.
- W4366285231 hasConceptScore W4366285231C41625074 @default.
- W4366285231 hasConceptScore W4366285231C43617362 @default.
- W4366285231 hasConceptScore W4366285231C55493867 @default.
- W4366285231 hasConceptScore W4366285231C86181022 @default.
- W4366285231 hasLocation W43662852311 @default.
- W4366285231 hasOpenAccess W4366285231 @default.
- W4366285231 hasPrimaryLocation W43662852311 @default.
- W4366285231 hasRelatedWork W2029683525 @default.
- W4366285231 hasRelatedWork W2037635908 @default.
- W4366285231 hasRelatedWork W2095124841 @default.
- W4366285231 hasRelatedWork W2107760138 @default.
- W4366285231 hasRelatedWork W2349694604 @default.
- W4366285231 hasRelatedWork W2364894328 @default.
- W4366285231 hasRelatedWork W2370079866 @default.
- W4366285231 hasRelatedWork W3136383441 @default.
- W4366285231 hasRelatedWork W3195455879 @default.
- W4366285231 hasRelatedWork W641462866 @default.
- W4366285231 isParatext "false" @default.
- W4366285231 isRetracted "false" @default.
- W4366285231 workType "article" @default.